A focus on governance and getting the right advice can help steer the board through financial uncertainty and mitigate potential liability.

Although investors’ contested resolutions have fallen, they are still mainly focused on executive pay, Georgeson report reveals.

AstraZeneca’s chief executive, Sir Pascal Soriot, tops the list with £16.85m, High Pay Centre research reveals.

The Institute of Directors’ ‘Manifesto for Business’ also seeks change to section 172 to promote company purpose.